Abstract:Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive and highly lethal malignancy. The majority of cases present with locally advanced unresectable or metastatic disease, which precludes surgical resection and makes cure virtually impossible. However, a subset of tumors with more indolent biology may be candidates for aggressive cytoreduction. Further, synchronous resection of oligometastatic disease is being investigated in prospective trials. We sought to develop a prognostic biomarker that could identify patients with low grade tumors. Methods: The Pancreatic Adenocarcinoma TCGA dataset was analyzed on the cBioPortal platform, comparing 173 patients with non-metastatic PDAC, known tumor grade, and available mRNAseq data. Well-differentiated (G1) tumors were compared to moderately (G2) or poorly differentiated (G3) patients to identify differentially expressed (ΔE) genes. The patients were split into training (n=138) and testing sets (n=35). Low-importance genes were eliminated using a combination of LASSO regression, recursive feature elimination, random forest (RF), and Boruta algorithms. SMOTE was employed to address minority class imbalance. Support vector machine (SVM), RF, and k-nearest neighbors (kNN) were independently trained for the binary classification of G1 vs G2/3 PDAC. The best model and hyperparameters were selected using the mean bootstrapped nested k-fold cross-validation F1-score and evaluated on the held-out test set. Lastly, the model predictions of grade were used to divide patients into two cohorts for Results: There were 1335 ΔE genes between G1 and G2/3 tumors. A panel of 7 genes were unanimously selected by the four low importance gene-elimination algorithms, and used for generation of predictive algorithms. In bootstrapped nested k-fold cross-validation of the training dataset, mean sensitivity and specificity were 0.98 and 0.91 for G1, respectively, and 0.91 and 0.97 for G2/3 PDAC. The kNN model performed best, with a mean F1-score of 0.942 (95% CI: [0.941, 0.943]) on the training set and 0.781 (95% CI: [0.776, 0.786]) for the test set. Conclusion: This study presents a novel machine learning-generated transcriptomic-based tool that predicts PDAC grade with good accuracy, and has the potential to identify less aggressive variants of PDAC that may be more amenable to aggressive cytoreductive approaches. Further testing and validation of the algorithm in larger datasets and using prospectively collected needle biopsy-acquired material is a worthwhile next step, to refine this into a potent clinical risk assessment tool. Citation Format: Daniel Fu, Constantinos P. Zambirinis. A machine learning-derived transcriptomic-based biomarker identifies low grade pancreatic ductal adenocarcinoma tumors and may help in treatment decision making [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Pancreatic Cancer; 2023 Sep 27-30; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(2 Suppl) nr A116.

Pancreatic Ductal Adenocarcinoma: Machine Learning–Based Quantitative Computed Tomography Texture Analysis for Prediction of Histopathological Grade

Machine Learning Methods Based on CT Features Differentiate G1/G2 from G3 Pancreatic Neuroendocrine Tumors.

Predictive Value of the Texture Analysis of Enhanced Computed Tomographic Images for Preoperative Pancreatic Carcinoma Differentiation.

SU‐E‐J‐256: Predicting Metastasis‐Free Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemo‐Radiotherapy by Data‐Mining of CT Texture Features of Primary Lesions

Diagnostic Accuracy of Unenhanced CT Texture Analysis to Differentiate Mass-Forming Pancreatitis from Pancreatic Ductal Adenocarcinoma

Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma

Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images

Dual-layer Spectral Detector CT: A Noninvasive Preoperative Tool for Predicting Histopathological Differentiation in Pancreatic Ductal Adenocarcinoma

CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma

Non-contrast-enhanced CT texture analysis of primary and metastatic pancreatic ductal adenocarcinomas: value in assessment of histopathological grade and differences between primary and metastatic lesions

Association of Radiomic Imaging Features and Gene Expression Profile As Prognostic Factors in Pancreatic Ductal Adenocarcinoma.

Resectable Pancreatic Ductal Adenocarcinoma: Association Between Preoperative CT Texture Features and Metastatic Nodal Involvement

Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics

Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18 F-FDG PET/CT radiomics

A Novel Multiresolution-Statistical Texture Analysis Architecture: Radiomics-Aided Diagnosis of PDAC Based on Plain CT Images

Value of CT-Based Texture Analysis in Preoperative Prediction of the Grade of Gastrointestinal Stromal Tumors Compared to Conventional CT Imaging

Application of CT texture analysis in predicting histopathological characteristics of gastric cancers

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma

Two-dimensional Texture Analysis Based on CT Images to Differentiate Pancreatic Lymphoma and Pancreatic Adenocarcinoma: A Preliminary Study.

Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma

Abstract A116: A machine learning-derived transcriptomic-based biomarker identifies low grade pancreatic ductal adenocarcinoma tumors and may help in treatment decision making